SCHEMBL18830239

SCHEMBL18830239

Cc1cnc(-c2ccc(-n3nnc4cnc(NC5CCCC5)nc43)cc2)nc1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 4/20 0.60
▸ GSK3B P49841 4/20 0.60
▸ MAPK6 Q16659 10/20 0.57
▸ TP53 P04637 3/20 0.43
▸ LMNA P02545 1/20 0.43
▸ AURKA O14965 2/20 0.42
▸ CDK4 P11802 1/20 0.41
▸ CCND1 P24385 1/20 0.41
▸ CCND2 P30279 1/20 0.41
▸ CCND3 P30281 1/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ MAPK8 P45983 1/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ EIF2AK4 Q9P2K8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18830331 0.86 MAPK6 (0.58) GSK3AGSK3BMAPK6TP53LMNA
SCHEMBL16022153 0.84 MAPK6 (0.67) GSK3AGSK3BMAPK6AURKAEIF2AK4
SCHEMBL5819986 0.83 GSK3A (0.81) GSK3AGSK3BMAPK6TP53LMNA
SCHEMBL18830445 0.82 GSK3A (0.64) GSK3AGSK3BMAPK6TP53LMNA
SCHEMBL18830621 0.82 GSK3A (0.67) GSK3AGSK3BMAPK6AURKACCNE1
SCHEMBL18830326 0.82 GSK3A (0.55) GSK3AGSK3BMAPK6TP53LMNA
SCHEMBL16012225 0.82 MAPK6 (0.82) GSK3AGSK3BMAPK6TP53AURKA
SCHEMBL18830194 0.81 GSK3A (0.62) GSK3AGSK3BMAPK6AURKACCNE1
SCHEMBL18830423 0.80 MAPK6 (0.67) GSK3AGSK3BMAPK6AURKACDK4
SCHEMBL16012274 0.80 MAPK6 (0.82) GSK3AGSK3BMAPK6TP53AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP disclosed
Send feedback